Literature DB >> 15774489

Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade.

Yongliang Zhu1, Xian Zhong, Shu Zheng, Zhen Ge, Qin Du, Suzhang Zhang.   

Abstract

It has been shown by epidemiological and animal studies that microcystin is an important exogenous factor involved in the carcinogenesis of colorectal cancer (CRC). However, details of the mechanism remain unclear. Transformation of colorectal cells is an important initial step in carcinogenesis. Whether microcystin is capable of transforming immortalized colorectal crypt cells, and what the mechanism might be, was investigated. In the present study, we demonstrated that immortalized colorectal crypt cells could be transformed by microcystin. Transformed colorectal crypt cells showed an anchorage-independent growth phenotype, and the proliferation activities of microcystin-transformed cells were also greater than that of immortalized colorectal crypt cells. The Akt and the p38, JNK of mitogen-activated protein kinase (MAPK) pathways in microcystin-transformed cells were found to be constitutively activated. In microcystin-transformed cells, PI3K, MAPKAPK2, Akt, cyclin D1 and cyclin D3 in the Akt pathway; IQGAP-2, RabGTPase, Rap1GAP, RasGAP, R-Ras, Krev-1 and TC21 of the Ras GTP/GDP protein family; and A-Raf, B-Raf and PAK in the Ras/MAPK pathway were all markedly upregulated. However, in positive control cells, dimethylhydrazine-transformed cells, only the Akt pathway was activated by PI3K, and no evidence of alteration of any molecules of the Ras superfamily was observed. Inhibition of Akt, p38 and JNK activation led to a reduced proliferation of microcystin-transformed cells. This implies that the constitutive activation of Akt and the p38, JNK of MAPK pathways in microcystin-transformed cells may be the mechanism by which this important external factor acts in the carcinogenesis of CRC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774489     DOI: 10.1093/carcin/bgi069

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts--indications of novel tumor-promoting cyanotoxins?

Authors:  Ludĕk Bláha; Pavel Babica; Klára Hilscherová; Brad L Upham
Journal:  Toxicon       Date:  2009-07-18       Impact factor: 3.033

2.  Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.

Authors:  Xian Zhong; Yongliang Zhu; Jianshan Mao; Jiawei Zhang; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-22       Impact factor: 4.553

3.  p53 Plays an important role in cell fate determination after exposure to microcystin-LR.

Authors:  Shota Takumi; Masaharu Komatsu; Tatsuhiko Furukawa; Ryuji Ikeda; Tomoyuki Sumizawa; Hitomi Akenaga; Yuta Maeda; Kohji Aoyama; Koji Arizono; Seiichi Ando; Toru Takeuchi
Journal:  Environ Health Perspect       Date:  2010-04-26       Impact factor: 9.031

4.  The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development.

Authors:  Romain M Larive; Antonio Abad; Clara M Cardaba; Teresa Hernández; Marta Cañamero; Enrique de Álava; Eugenio Santos; Balbino Alarcón; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2012-04-25       Impact factor: 4.138

Review 5.  Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities.

Authors:  Tan Li; Guanyu Wang
Journal:  Int J Mol Sci       Date:  2014-10-20       Impact factor: 5.923

6.  HOXB4 Mis-Regulation Induced by Microcystin-LR and Correlated With Immune Infiltration Is Unfavorable to Colorectal Cancer Prognosis.

Authors:  Lingqiao Wang; Huidong Jin; Yi Zeng; Yao Tan; Jia Wang; Wenjuan Fu; Weiyan Chen; Ke Cui; Zhiqun Qiu; Ziyuan Zhou
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

Review 7.  Review of Cyanotoxicity Studies Based on Cell Cultures.

Authors:  Iliyana Sazdova; Milena Keremidarska-Markova; Mariela Chichova; Blagoy Uzunov; Georgi Nikolaev; Mitko Mladenov; Rudolf Schubert; Maya Stoyneva-Gärtner; Hristo S Gagov
Journal:  J Toxicol       Date:  2022-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.